LASEZKAY GEORGE M (Interim CEO) sold 3.7% of their position (18K shares) of CLEARSIDE BIOMEDICAL, INC. on the open market
Open‑market sale worth $22.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/19/2024ACC: 0001209191-24-001960
DirectorOfficer· Interim CEO
Since Apr 2019
+421.50K
Net shares
Net buyer
$22.9K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
439.50K acquired · 18K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−18K
Price / share
$1.27
Trade value
$22.86K
% of position
3.7%
1/19/2024
484.58K→466.58K
Total
Net shares
−18K
Net value
-$22.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/19/2024 | S · Sale | −18K | $1.27 | $22.86K | 3.7% | 484.58K | 466.58K |
| Total | −18K | -$22.86K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
439.50K shares
Shares
+439.50K
Strike price
1.29
Held after
439.50K
Exercisable
—
1/18/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock439.50K shares | 1/18/2024 | A · Award | +439.50K | 1.29 | — | 439.50K |